Remove Diabetes Remove Hypertension Remove Patient Care
article thumbnail

America’s Hypertension Awareness and Control Problem

CardiacWire

Nearly half of American adults have hypertension, and a new JAMA study reveals that the vast majority of them don’t have their blood pressure under control, while most don’t even know they have the disease. adults have hypertension, while uncontrolled hypertension is associated with $131B-$198B in annual healthcare costs.

article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. One promising strategy is the formation of creative partnerships between patients and their healthcare teams.

article thumbnail

What’s wrong with the NHS? – Part 4

Dr. Malcolm Kendrick

Here, for example, plucked at random, is a reference to the latest NICE guidelines on the management of hypertension (high blood pressure) in adults. But this, the primary guideline on hypertension for adults, is but one of many. There are associated guidelines on hypertension in pregnancy. Primary care, secondary care.

article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

Staying informed about these cutting-edge developments is critical for providing exceptional patient care. Join us as we examine the landmark approvals that are revolutionizing patient outcomes. The first half of 2024 has ushered in a wave of transformative FDA approvals in cardiorenal metabolic health.

article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

ET Main Tent (Hall B1) Effect of Gamification, Financial Incentives or Both Combined to Increase Physical Activity Among Patients with Elevated Risk For Major Adverse Cardiovascular Events. 24 and how those may impact clinical practice and patient care in this deep dive clinical trial session. 12:15 p.m.

article thumbnail

Reaching the Underserved in Rural America

The Beat Blog

3 Access to timely quality care becomes more and more of a challenge for too many rural communities – and hospitals and payers continue to look for solutions to address this intractable problem. The demand for cardiovascular care, for example, continues to grow at an almost exponential rate.